PolyPid Announces FDA Acceptance of NDA with Priority Review for D-PLEX₁₀₀

Go back to PolyPid Announces FDA Acceptance of NDA with Priority Review for D-PLEX₁₀₀
(NASDAQ: PYPD) Delayed: 5.23 -0.1 (1.88%)
Previous Close $5.33    52 Week High
Open $5.22    52 Week Low
Day High $5.39    P/E N/A 
Day Low $5.16    EPS
Volume 117,091